CurrentCardio
Get Weekly

CurrentCardio coverage · page 4 of 8

JACC: Heart Failure

Briefs 121–160 of 317 CurrentCardio has covered from this journal, newest publication first

Latest from JACC: Heart Failure

All coverage, newest first

  1. JACC Heart Fail

    Obesity and Risk of Kidney Outcomes in Heart Failure With Preserved Ejection Fraction: A Participant-Level Pooled Analysis of 4 Contemporary Trials

    Meta-analysisHeart failure

  2. JACC Heart Fail

    Association of the 2018 U.S. Heart Allocation Policy Change and the Survival Benefit of Heart Transplantation

    Cohort studyHeart failure

  3. JACC Heart Fail

    Sex Differences in Diabetic Cardiomyopathy and Treatment Response to AT-001: Insights From the ARISE-HF Study

    Secondary analysisHeart failure

  4. JACC Heart Fail

    LV Structure and Function in HFrEF With and Without Peak-Flow-Triggered Adaptive Servo-Ventilation-Treated Sleep-Disordered Breathing

    Secondary analysisHeart failure

  5. JACC Heart Fail

    The p.Asn271Ile Variant in the TNNT2 Gene Is Associated With Low-Risk Late-Onset Hypertrophic Cardiomyopathy

    Cohort studyHeart failure

  6. JACC Heart Fail

    Outcomes After Donation After Circulatory Determination of Death Cardiac Transplantation: An International, Multicenter Retrospective Study

    Cohort studyHeart failure

  7. JACC Heart Fail

    Results of the Precision Event Monitoring for Patients With Heart Failure Using HeartLogic Study (PREEMPT-HF)

    Cohort studyHeart failure

  8. JACC Heart Fail

    Effects of Atrial Fibrillation Ablation for Heart Failure With Preserved Ejection Fraction: Insights From CABANA

    Secondary analysisArrhythmias & EP

  9. JACC Heart Fail

    The Antifibrotic Effects of Eplerenone in Hypertrophic Cardiomyopathy: A Randomized Clinical Trial

    Randomised controlled trialHeart failure

  10. JACC Heart Fail

    First-in-Human Implantable Inferior Vena Cava Sensor for Remote Care in Heart Failure: FUTURE-HF

    Research articleHeart failure

  11. JACC Heart Fail

    Prospective Validation and Implementation Pilot Study of an Emergency Department Heart Failure Risk Stratification Tool: STRIDE-HF

    Diagnostic or prognostic studyHeart failure

  12. JACC Heart Fail

    Concomitant Surgical Procedures and Aspirin Avoidance With Left Ventricular Assist Device Therapy

    Secondary analysisHeart failure

  13. JACC Heart Fail

    Body Composition and Survival in Patients With Heart Failure: A Systematic Review and Meta-Analysis

    Meta-analysisHeart failure

  14. JACC Heart Fail

    Finerenone Across the Spectrum of Kidney Risk in Heart Failure: The FINEARTS-HF Trial

    Secondary analysisHeart failure

  15. JACC Heart Fail

    Finerenone and NYHA Functional Class in Heart Failure: The FINEARTS-HF Trial

    Secondary analysisHeart failure

  16. JACC Heart Fail

    Crossover Trial of Exogenous Ketones on Cardiometabolic Endpoints in Heart Failure With Preserved Ejection Fraction

    Randomised controlled trialHeart failure

  17. JACC Heart Fail

    Association of Extracoronary Calcification and Incident Heart Failure in the Multiethnic Study of Atherosclerosis (MESA)

    Cohort studyHeart failure

  18. JACC Heart Fail

    Direct-to-Physician Marketing and Uptake of Optimal Medical Therapy for Heart Failure With Reduced Ejection Fraction

    Cohort studyHeart failure

  19. JACC Heart Fail

    Influence of Obesity on Invasive Hemodynamics and Prognosis in Patients With Heart Failure

    Cohort studyHeart failure

  20. JACC Heart Fail

    Validation of Guideline Recommendation on Sudden Cardiac Death Prevention in Hypertrophic Cardiomyopathy

    Cohort studyHeart failure

  21. JACC Heart Fail

    Effects of Sacubitril/Valsartan According to Natriuretic Peptide Levels in Patients Enrolled in PARADIGM-HF and PARAGON-HF

    Meta-analysisHeart failure

  22. JACC Heart Fail

    Interleukin-6 in Heart Failure With Reduced Ejection Fraction and the Effect of Dapagliflozin: An Exploratory Analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Heart Failure Trial

    Secondary analysisHeart failure

  23. JACC Heart Fail

    Stroke in Heart Failure With Reduced Ejection Fraction: Systematic Review and Meta-Analysis of Randomized Trials

    Meta-analysisHeart failure

  24. JACC Heart Fail

    Glucagon-Like Peptide 1 Receptor Agonist Is Associated With Improved Survival in Overweight Heart Failure Patients

    Cohort studyHeart failure

  25. JACC Heart Fail

    Growth Hormone Replacement Therapy in Heart Failure With Reduced Ejection Fraction: A Randomized, Double-Blind, Placebo-Controlled Trial

    Randomised controlled trialHeart failure

  26. JACC Heart Fail

    Global Burden of Pulmonary Arterial Hypertension and Associated Heart Failure: Global Burden of Disease 2021 Analysis

    Secondary analysisPulmonary vascular & VTE

  27. JACC Heart Fail

    Severe Heart Failure and Treatment With Dapagliflozin Across the Ejection Fraction Spectrum: DAPA-HF and DELIVER

    Secondary analysisHeart failure

  28. JACC Heart Fail

    Prognostic Implications and Global Perspectives of Atrial Fibrillation in Patients Hospitalized for Heart Failure

    Cohort studyHeart failure

  29. JACC Heart Fail

    Disparities Among Immigrants and Native Patients in Denmark With New-Onset Heart Failure With Reduced Ejection Fraction

    Cohort studyHeart failure

  30. JACC Heart Fail

    Outcomes of KDIGO-Defined CKD in U.S. Veterans With HFpEF, HFmrEF, and HFrEF

    Cohort studyHeart failure

  31. JACC Heart Fail

    Beta-Blockers and Long-Term Mortality in Takotsubo Syndrome: Results of the Multicenter GEIST Registry

    Cohort studyHeart failure

  32. JACC Heart Fail

    Center- vs Home-Based Cardiac Rehabilitation in Patients With Heart Failure: EXIT-HF Randomized Controlled Trial

    Randomised controlled trialHeart failure

  33. JACC Heart Fail

    Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Preserved Trial

    Secondary analysisHeart failure

  34. JACC Heart Fail

    Effects of Acute Phase Intensive Exercise Training in Patients With Acute Decompensated Heart Failure

    Randomised controlled trialHeart failure

  35. JACC Heart Fail

    Adverse Pregnancy Outcomes and Long-Term Risk of Heart Failure in Women: National Cohort and Co-Sibling Study

    Cohort studyHeart failure

  36. JACC Heart Fail

    Elevated Neutrophil-to-Lymphocyte Ratio Predicts Prognosis in Acute Myocarditis

    Cohort studyHeart failure

  37. JACC Heart Fail

    Growth Differentiation Factor–15 Is Associated With Congestion-Related Anorexia and Weight Loss in Advanced Heart Failure

    Cohort studyHeart failure

  38. JACC Heart Fail

    Left Ventricular Dimensions and Clinical Outcomes With a Fully Magnetically Levitated Left Ventricular Assist Device

    Secondary analysisHeart failure

  39. JACC Heart Fail

    Upgrading Right Ventricular Pacing to Cardiac Resynchronization in HFrEF Patients Improves Symptoms and Functional Outcomes

    Secondary analysisHeart failure

  40. JACC Heart Fail

    Decongestion and Outcomes in Patients Hospitalized for Acute Heart Failure: Insights From the RELAX-AHF-2 Trial

    Secondary analysisHeart failure

All 317 Briefs in ExploreShowing Briefs 121–160 of 317, newest first